Jing Chinese Medicine Acupuncture Or Li is categorized under Acupuncturists in Oakland, CA and active since 2001.
Jing Chinese Medicine Acupuncture Or Li was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number 621399 by the NAICS.
If you are seeking more information, feel free to contact Jing Li at the company’s single location by writing to 4414 Piedmont Avenue, Oakland, California CA 94611 or by phoning (510) 654-1567. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jing Chinese Medicine Acupuncture Or Li |
| Contact Person: | Jing Li |
| Address: | 4414 Piedmont Avenue, Oakland, California 94611 |
| Phone Number: | (510) 654-1567 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Acupuncturists |
| SIC Code: | 8049 |
| NAICS Code: | 621399 |
| Share This Business: |
Jing Chinese Medicine Acupuncture Or Li was started in 2001 to provide professional Acupuncturists under the SIC code 8049 and NAICS code 621399. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Jing Li for inquiries that concern Jing Chinese Medicine Acupuncture Or Li by calling the company number (510) 654-1567, as your correspondence is most welcome. Additionally, the physical location of the single location of Jing Chinese Medicine Acupuncture Or Li can be found at the coordinates 37.830471,-122.246813 as well as the street address 4414 Piedmont Avenue in Oakland, California 94611.
For its online presence, you may visit Jing Chinese Medicine Acupuncture Or Li’s website at and engage with its social media outlets through on Twitter and on Facebook.